All

Results: 34705-34716 of 79106

PR Newswire associated0

Alma Unveils Alma IQ at Eighth Global Alma Academy in Dubrovnik

PR Newswire associated0

Valvoline™ Global Operations Confirmed as Official FIFA World Cup 26™ Supporter

MORE PATIENTS ACROSS ENGLAND AND WALES ARE SET TO BECOME ELIGIBLE FOR ASTRAZENECA’S FORXIGA (DAPAGLIFLOZIN) FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE

PR Newswire associated0

Highlights of ESHG | Rapid AI Karyotype Total Solution From China Makes a Big Splash

PR Newswire associated0

Gaming Reimagined: Infinix GT VERSE Merges Power, Play, and Portability in One Seamless Ecosystem

PR Newswire associated0

SERES Invited to Attend ASEAN-China-GCC Economic Forum

Announcement of change in the total number of votes in AB SKF

New number of shares and votes in Telefonaktiebolaget LM Ericsson

Iksuda Therapeutics announces first patient successfully dosed in phase 1 trial evaluating IKS03 in advanced B cell non-Hodgkin lymphomas

PR Newswire associated0

Bridal Disrupted: How Azazie Is Transforming the UK Wedding Scene, One Pop-Up at a Time

The first and only retrievable stent system that features a self-expanding stent with an integrated dilatation balloon catheter on an over-the-wire system. It is designed for controlled lesion penetration and treatment through a series of radially expandable spikes. Known as Retrievable Scaffold Therapy (RST), the spikes on the Spur Stent penetrate the lesion to increase the acute luminal diameter and modify the lesion morphology to change vessel compliance and reduce vessel recoil effect.

FDA Grants De Novo Clearance for Reflow Medical's Spur® Peripheral Retrievable Stent System

PR Newswire associated0

Xinhua Silk Road: 2025 Maritime Silk Road Port Cooperation Forum highlights ports green, intelligent dev't